以往的研究表明大约25% - 30%的患者会发生移植后的白血病复发。
Previous research studies have also shown that about 25 to 30 percent of patients suffer leukemia relapse after transplant.
结论：(1)供者白细胞的输注能使某些BMT后慢性粒细胞性白血病遗传学及血液学复发患者完全缓解。
Conclusion: (1) Donor derived leukocyte infusion can induce CML post BMT to cytogenetic and hematological CR. It has also therapeutic effects on acute leukemia relapse but is less sustained.
白血病、癌症患者在短期内得到救治，提高自身免疫功能，度过高危复发期。
Leukemia, cancer patients have been treated in the short term to improve their immune function, through high-risk relapse period.
应用推荐